Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Klinique Medical Clinic PCL's EBIT per Share for the
three
months ended in Mar. 2026 was ฿0.74.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ฿2.44.
During the past 12 months, the average EBIT per Share Growth Rate of The Klinique Medical Clinic PCL was 26.30% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 12.80% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 17.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for The Klinique Medical Clinic PCL's EBIT per Share or its related term are showing as below:
BKK:KLINIQ'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 12.8 Med: 14.3 Max: 23.5
Current: 12.8
During the past 7 years, the highest 3-Year average EBIT per Share Growth Rate of The Klinique Medical Clinic PCL was 23.50% per year. The lowest was 12.80% per year. And the median was 14.30% per year.
BKK:KLINIQ's 3-Year EBIT Growth Rate is ranked better than 51.47% of 68
companies
in the Personal Services industry
Industry Median: 12.55
vs BKK:KLINIQ: 12.80
The Klinique Medical Clinic PCL (BKK:KLINIQ) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
The Klinique Medical Clinic PCL EBIT per Share Related Terms
The Klinique Medical Clinic PCL EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Klinique Medical Clinic PCL EBIT per Share Chart
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿2.44
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Klinique Medical Clinic PCL (BKK:KLINIQ) has a EBIT per Share of ฿2.44 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on The Klinique Medical Clinic PCL and its competitors. According to the industry distribution chart, The Klinique Medical Clinic PCL ranks #33 out of 68 companies in the Personal Services industry, placing it in the top 48.5%.
Is The Klinique Medical Clinic PCL's EBIT per Share too high?
The Klinique Medical Clinic PCL's current EBIT per Share is ฿2.44. Based on the distribution chart, The Klinique Medical Clinic PCL ranks #33 out of 68 companies in the Personal Services industry, which is above the industry midpoint. Overall, The Klinique Medical Clinic PCL has a GF Score™ of 90/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Klinique Medical Clinic PCL's EBIT per Share compare to ROL and SCI?
According to the Personal Services industry distribution chart, The Klinique Medical Clinic PCL ranks #33 out of 68 companies for EBIT per Share. This puts The Klinique Medical Clinic PCL in the upper half of its industry. The industry median EBIT per Share is 12.55. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Personal Services company?
The median EBIT per Share among Personal Services companies is 12.55, based on 68 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on The Klinique Medical Clinic PCL and its competitors. For the Personal Services industry, the median EBIT per Share is 12.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Klinique Medical Clinic PCL's current EBIT per Share is ฿2.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Klinique Medical Clinic PCL stock overvalued right now?
Based on GuruFocus' analysis, The Klinique Medical Clinic PCL (BKK:KLINIQ) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿44.60, compared to a current price of ฿27.75 — trading 37.8% below its estimated fair value. The current EBIT per Share is ฿2.44. The Klinique Medical Clinic PCL's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For The Klinique Medical Clinic PCL (BKK:KLINIQ), the current EBIT per Share is ฿2.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Klinique Medical Clinic PCL (BKK:KLINIQ) Overvalued in 2026?
Based on GuruFocus' analysis, The Klinique Medical Clinic PCL stock appears to be undervalued.
The current stock price of ฿27.75 is trading 37.8% below its estimated GF Value™ of ฿44.60.
GuruFocus considers The Klinique Medical Clinic PCL to be Significantly Undervalued.
Key valuation signals for BKK:KLINIQ:
EBIT per Share: ฿2.44
GF Value™: ฿44.60 vs. price of ฿27.75 (37.8% below fair value)
No single metric tells the full story. See the BKK:KLINIQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The Klinique Medical Clinic PCL Business Description
The Klinique Medical Clinic PCL provides skin care services, beauty, skin care, body contouring, and surgery. including providing holistic care services. The company has a wide range of services and products to meet the needs of customers at all levels, such as facial treatment services, reducing redness, reducing dark spots, laser services for face lifting, face reshaping, skin care, Body shape by removing and dissolving fat, cosmetic surgery, etc. In addition, the company also sells cosmeceuticals. There are various types of products, such as Special Care, Clean & Prepare, Whitening Set, Sun Care, and Antioxidant. The group operates two core business segments: Skin medical services and distribution of cosmetics and medical cosmetics; and Surgery services.
90GF Score
Get the complete analysis for BKK:KLINIQ
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:KLINIQ has been successfully added to your 
